Compare Asia Pramulia Tbk. (ASPR) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Asia Pramulia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Asia Pramulia Tbk. trades at Rp143 (market cap 393.24B, 23.66M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Asia Pramulia Tbk. is more actively traded (23.66M versus 1.44M). Which is the better fit depends on your goals.
| ASPR | LABS | |
|---|---|---|
Market Cap | 393.24B | 584.6B |
Volume | 23.66M | 1.44M |
Lot | 236.55K | 14.4K |
Turnover | 3.35B | 209.72M |
Average Price | 141.58 | 145.64 |
Value | 3.35B | 209.72M |
Indicative Equilibrium Price | 143 | 146 |
Indicative Equilibrium Volume | 7.69K | 753 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Asia Pramulia Tbk.
PT Asia Pramulia Tbk (Entity) was established based on deed No. 193 dated July 29, 1991 from Noor Irawati, S.H., Notary in Surabaya.
Read more on ASPR →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
